Since the COVID-19 pandemic made us experts on the issue, we all know it’s a respiratory disease. Though that’s 100 % true, in the long-term it doesn’t seem to be completely right. Your brain also suffers and you could be a COVID-19 patient for up to 6 months, concerning mental health. These symptoms are identified as a long haul COVID-19, and include a variety of lingering long-term health issues. But should we beware of the next mental health surge?
The so-called ‘long haulers’ express multiple difficulties and describe a wide range of cardiovascular health issues. A few studies over the past years already urged on extending the interdisciplinary care and support for their COVID-19 patients. Many recovered COVID-19 patients describe they have troubles in memorization and concentration. Plus they find it hard to remember things, and are easily exhausted, comparing their previously daily activity.
Most common post acute COVID-19 symptoms are chronic fatigue, anxiety, depression, even insomnia, PTSD (post traumatic stress disorder) and dementia. What’s most intimidating, children who had COVID-19 don’t have the insurance of not suffering from one of those, too. The cognitive challenges, expressed due to the damages SARS-CoV-2 does to the heart, kidneys, lungs and a whole range of organs, are now defined as a ‘brain fog’.
the cognitive & behavioral neurologist Andrew E. Budson says in his column for Harvard Health Blog. He also gives some advice on sleep hygiene, exercising, participating in social activities and avoiding alcohol and drugs. Though going back to normal can be quite a difficult experience, reading a novel, listening to music and other cognitive stimulating activities. The specialist urges a healthy diet, because stressful situations may occur, as due to the present pandemic outbreak.
By attacking nose olfactory cells, the SARS-CoV-2 virus gets straight to the brain. This happens by reaching the olfactory bulb and moving just next to the hippocampus. So that’s exactly how tracking the inflammation explains both the loss of taste/smell and cognitive decline in so many susceptible individuals.
A recent study of Lancet Psychiatry journal, also found some amazing links. It regards to COVID-19 survivors and a higher risk of developing a mental illness. The analysis included 69 million people in the United States, with more than 62,000 cases of COVID-19. The results came to conclude that 1 of 5 had his first diagnosis of anxiety, depression or insomnia. Those who had pre-existing mental issues before were 65 % more likely to become COVID-19 patients, compared to those without.
While much more data appears to be collected so far, a new study by the same team took place in the 6 April 2021. As led by Paul Harrison of the University of Oxford, it tracked the outcomes of more than 236,000 COVID-19 patients, mostly in the USA. It triggered most accurately on 14 mental health disorders and found 34 % of them were diagnosed with such disorders in the 6 months after being infected with the nobel coronavirus.
It also stressed on the fact that as severe the COVID-19 symptoms are, as greater the risk of developing psychiatric and neurologic illness is. It’s more important what happens after these 6 months. But it requires additional research, with a view to preventing or treating them.
Nowadays, we divide time on before and after the pandemic. If we had already experienced enough stress in the past, during the coronavirus pandemic outbreak it’s getting more powerful. Long haul COVID-19 and people dealing with it worldwide is tremendous and it’s constantly rising. Though mental health is a part of a bigger picture, it’s important that we focus on the consequences of the coronavirus survivors.
MVS Pharma GmbH is an innovative pharmaceutical start-up company, which researches in the area of reducing viruses and bacteria with plant based aerosols. Their special formula ensures the purity and the stability of the used ingredients during storage.
Liliya Ganeva is an article writer, who explores all the actual, up-to-date COVID-19 information, and the possibilities for producing aerosols made out of plants against respiratory viruses and bacteria.